Efficacy of treatment of bronchial asthma attack in teenagers with partial control over the disease

Authors

DOI:

https://doi.org/10.32782/2415-8127.2026.73.11

Keywords:

bronchial asthma, children, adolescents, bronchial hyperreactivity, inflammation of the bronchi

Abstract

The goal of the research is to evaluate efficacy of treatment of bronchial asthma attack considering hypersusceptibility indices of the respiratory tract to indirect bronchospasmogenic stimulus in teenagers with a partial control over the disease.
The effectiveness of therapy was analyzed according to the severity of bronchial sensitivity to dosed physical activity in 40 adolescents with partially controlled asthma. The patients were randomized. An average age was 14,3±0,2 years, and duration of the disease – (8,0±0,4) years. Considering the index of bronchial instability in teenagers with a partial control over the disease, two clinical groups of observation were formed. The first group included 16 teenagers with the index of bronchial instability more than 25%, and the second group included 24 peers with less pronounced bronchial instability (less 25%). All the children were comprehensively clinically-paraclinically examined, including evaluation of severity of bronchial obstructive syndrome, immunological tests I-II levels, inflammatometry of expired air condensate and spirometry with nonspecific provocation testing. Bronchial instability index (BII) was calculated and nonspecific hypersusceptibility of the bronchi to indirect stimulus (physical exercise) was examined by means of testing with physical exercise followed by inhalation of bronchodilators. Nonspecific hypersusceptibility of the bronchi to direct stimuli was examined by means of inhalation spirometric test with histamine series solutions calculating histamine provocation concentration (PC20, mg/ml) and provocation dose (PD20, mg), decreasing forced expiratory volume (FEV1) to 20% from the initial level.
Evaluation of deobstructive therapy efficacy of bronchial asthma attack in teenagers with a partial control over the disease gives the evidence to consider that during the first days of treatment it should be more active and extensional in teenagers with high bronchial instability, especially in those cases when a child belongs to the cluster of a high risk of development of severe attack of the disease on the basis of the preliminary comprehensive examination. Patients with high bronchial instability received glucocorticosteroids in a comprehensive treatment more often, for example, in 56,3% cases in the form of systemic pharmacological agents. Risk indices of glucocorticosteroid use in patients from I group (BII>25%) in comparison with ІІ group (BII<25%) were the following: 1,5 [95%CІ:1,1-4,6], with odds ratio 5,3 [95%CІ:2,5-10,9].

References

Abecassis L, Gaffin JM, Forbes PW, Schenkel SR, McBride S, DeGrazia M. Validation of the Hospital Asthma Severity Score (HASS) in children ages 2–18 years old. J Asthma. 2022;59(2):315-324.

Bahmani AHA, Vijverberg SJ, Hashimoto S, Wolff C, Almqvist C, Bloemsma LD, et al. Association of blood inflammatory phenotypes and asthma burden in children with moderate-to-severe asthma. ERJ Open Res. 2024;10(6):00647-2024.

Bai J, Li X, Wang Y, Chen Z. Airway inflammation, bronchial hyperresponsiveness, and anti-asthma treatment response in classic and cough-variant asthma. BMC Pulm Med. 2025;25:3627.

Busse WW, Chupp G, Corbridge T, Stach-Klysh A, Oppenheimer J. Targeting asthma remission as the next therapeutic step toward improving disease control. J Allergy Clin Immunol Pract. 2024;12(4):894–903.

Eller MCN, Pierantozzi-Vergani K, Saraiva-Romanholo BM, de Souza Xavier Costa N, de Brito JM, Antonangelo L, et al. Bronchial eosinophils, neutrophils, and CD8+ T cells influence asthma control and lung function in schoolchildren and adolescents with severe treatment-resistant asthma. Respir Res. 2022;23(1):335.

Habib N, Pasha MA, Tang DD. Current understanding of asthma pathogenesis and biomarkers. Cells. 2022;11(17):2764.

Honkamäki J, Piirilä P, Hisinger-Mölkänen H, Tuomisto LE, Andersén H, Huhtala H, et al. Asthma remission by age at diagnosis and gender in a population-based study. J Allergy Clin Immunol Pract. 2021;9(5):1950–1959.

Hsieh A, Assadinia N, Hackett TL. Airway remodeling heterogeneity in asthma and its relationship to disease outcomes. Front Physiol. 2023;14:1113100.

Huang Y, Qiu C. Research advances in airway remodeling in asthma: a narrative review. Ann Transl Med. 2022;10(18):1023.

Kardas G, Panek M, Kuna P, Damiański P. Monoclonal antibodies in the management of asthma: dead ends, current status and future perspectives. Front Immunol. 2022;13:983852.

Kim RY, Pinkerton JW, Oliver BG. Update on inflammatory biomarkers for defining asthma phenotype. Allergy Asthma Immunol Res. 2024;16(5):462–475.

Koefoed HJL, Ullah A, Merid SK, Lowe L, Vermeulen R, Kere MM, et al. Childhood lung function is associated with adolescent-onset and persistent asthma. Eur Respir J. 2024;63(5):2301234.

Downloads

Published

2026-05-29

How to Cite

Shakhova, O. O., Tarnavska, S. I., & Ganyk, D. O. (2026). Efficacy of treatment of bronchial asthma attack in teenagers with partial control over the disease. Scientific Bulletin of the Uzhhorod University. Series «Medicine», (1(73), 63-68. https://doi.org/10.32782/2415-8127.2026.73.11